Update: Pro Medicus Posts 29% Rise in Fiscal 2024 Revenue; EPS Up, Beats Estimates; Shares Up 8%

MT Newswires Live08-14

Update: Pro Medicus Posts 29% Rise in Fiscal 2024 Revenue; EPS Up, Beats Estimates; Shares Up 8% (Updates to add stock movement in the headline and the first paragraph, and the company's outlook in ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

darr_en1
08-23
darr_en1
Q

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2459416052?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2024-08-14 10:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2459416052","market":"hk","top_or_hot":-1,"title":"Update: Pro Medicus Posts 29% Rise in Fiscal 2024 Revenue; EPS Up, Beats Estimates; Shares Up 8%","media":"MT Newswires Live","content":"<div>\n<p>Update: Pro Medicus Posts 29% Rise in Fiscal 2024 Revenue; EPS Up, Beats Estimates; Shares Up 8% (Updates to add stock movement in the headline and the first paragraph, and the company's outlook in ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">网页链接</a>\n\n</div>\n","source":"mtnewswires_live","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Update: Pro Medicus Posts 29% Rise in Fiscal 2024 Revenue; EPS Up, Beats Estimates; Shares Up 8%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUpdate: Pro Medicus Posts 29% Rise in Fiscal 2024 Revenue; EPS Up, Beats Estimates; Shares Up 8%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-14 10:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Update: Pro Medicus Posts 29% Rise in Fiscal 2024 Revenue; EPS Up, Beats Estimates; Shares Up 8% (Updates to add stock movement in the headline and the first paragraph, and the company's outlook in ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7094","symbol_name":"医疗保健技术","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2459416052","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2459416052","pubTimestamp":1723601936,"columns":[],"sourceInfo":{"source_id":"mtnewswires_live","name":"MT Newswires Live"},"weMediaInfo":null,"summary":"Update: Pro Medicus Posts 29% Rise in Fiscal 2024 Revenue; EPS Up, Beats Estimates; Shares Up 8% (Up","collect":0,"end_time":0,"defaultTopTitle":"mtnewswires.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7094":"医疗保健技术","BK4212":"包装食品与肉类","BK4125":"广播","AFG":"美国金融集团有限公司","PME.AU":"PRO MEDICUS LTD","BK4117":"多元化保险","BK4107":"财产与意外伤害保险","PME":"平潭海洋实业有限公司","AUD":"Audacy Inc."},"translate_title":"更新：Pro Medicus公布2024财年收入增长29%；每股收益上升，超出预期；股价上涨8%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AFG":1,"AUD":1,"PME":1,"PME.AU":1},"content_text":"Update: Pro Medicus Posts 29% Rise in Fiscal 2024 Revenue; EPS Up, Beats Estimates; Shares Up 8% (Updates to add stock movement in the headline and the first paragraph, and the company's outlook in the third and fourth paragraphs)Pro Medicus (ASX:PME) shares rose nearly 8% in morning trade Wednesday as the company reported that its earnings per share in the year ended June 30 rose to AU$0.791, compared with the prior-year period's AU$0.58.Analysts polled by Visible Alpha were expecting EPS of AU$0.7566.In fiscal 2025, the company anticipates increased opportunities due to improved North American prospects for the Visage 7 imaging platform and continued commercialization of Visage RIS.Additionally, the company's performance is expected to be influenced by increased revenue from transaction-based contracts, which are set to commence in fiscal 2025.Earlier, the company reported that its revenue from ordinary activities was AU$161.5 million, up over 29% from AU$124.9 million in the same period last year. The Visible Alpha average estimate was for revenue of AU$160.9 million.The imaging IT provider declared a fully franked final dividend of AU$0.22 per share with a record date of Sept. 5 payable on Sept. 26.Price (AUD): $141.77, Change: $+10.18, Percent Change: +7.74%","kind":"live","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":341512568738072,"gmtCreate":1724397642356,"gmtModify":1724397643902,"author":{"id":"3582150937501213","authorId":"3582150937501213","name":"darr_en1","avatar":"https://static.tigerbbs.com/29b43343d665325c3836b6c1b6604f7f","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3582150937501213","authorIdStr":"3582150937501213"},"htmlText":"Q","listText":"Q","text":"Q","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/341512568738072","repostId":2459416052,"repostType":2,"repost":{"id":"2459416052","kind":"live","pubTimestamp":1723601936,"share":"https://www.laohu8.com/m/news/2459416052?lang=&edition=full","pubTime":"2024-08-14 10:18","market":"hk","language":"en","title":"Update: Pro Medicus Posts 29% Rise in Fiscal 2024 Revenue; EPS Up, Beats Estimates; Shares Up 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459416052","media":"MT Newswires Live","summary":"Update: Pro Medicus Posts 29% Rise in Fiscal 2024 Revenue; EPS Up, Beats Estimates; Shares Up 8% (Up","content":"<html><body><p>Update: Pro Medicus Posts 29% Rise in Fiscal 2024 Revenue; EPS Up, Beats Estimates; Shares Up 8%</p><p> (Updates to add stock movement in the headline and the first paragraph, and the company's outlook in the third and fourth paragraphs)</p><p>Pro Medicus (ASX:PME) shares rose nearly 8% in morning trade Wednesday as the company reported that its earnings per share in the year ended June 30 rose to AU$0.791, compared with the prior-year period's AU$0.58.</p><p>Analysts polled by Visible Alpha were expecting EPS of AU$0.7566.</p><p>In fiscal 2025, the company anticipates increased opportunities due to improved North American prospects for the Visage 7 imaging platform and continued commercialization of Visage RIS.</p><p>Additionally, the company's performance is expected to be influenced by increased revenue from transaction-based contracts, which are set to commence in fiscal 2025.</p><p>Earlier, the company reported that its revenue from ordinary activities was AU$161.5 million, up over 29% from AU$124.9 million in the same period last year. The Visible Alpha average estimate was for revenue of AU$160.9 million.</p><p>The imaging IT provider declared a fully franked final dividend of AU$0.22 per share with a record date of Sept. 5 payable on Sept. 26.</p><p>Price (AUD): $141.77, Change: $+10.18, Percent Change: +7.74%</p></body></html>","source":"mtnewswires_live","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Update: Pro Medicus Posts 29% Rise in Fiscal 2024 Revenue; EPS Up, Beats Estimates; Shares Up 8%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUpdate: Pro Medicus Posts 29% Rise in Fiscal 2024 Revenue; EPS Up, Beats Estimates; Shares Up 8%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-14 10:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Update: Pro Medicus Posts 29% Rise in Fiscal 2024 Revenue; EPS Up, Beats Estimates; Shares Up 8% (Updates to add stock movement in the headline and the first paragraph, and the company's outlook in ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK7094":"医疗保健技术","BK4212":"包装食品与肉类","BK4125":"广播","AFG":"美国金融集团有限公司","PME.AU":"PRO MEDICUS LTD","BK4117":"多元化保险","BK4107":"财产与意外伤害保险","PME":"平潭海洋实业有限公司","AUD":"Audacy Inc."},"source_url":"https://www.mtnewswires.com/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2459416052","content_text":"Update: Pro Medicus Posts 29% Rise in Fiscal 2024 Revenue; EPS Up, Beats Estimates; Shares Up 8% (Updates to add stock movement in the headline and the first paragraph, and the company's outlook in the third and fourth paragraphs)Pro Medicus (ASX:PME) shares rose nearly 8% in morning trade Wednesday as the company reported that its earnings per share in the year ended June 30 rose to AU$0.791, compared with the prior-year period's AU$0.58.Analysts polled by Visible Alpha were expecting EPS of AU$0.7566.In fiscal 2025, the company anticipates increased opportunities due to improved North American prospects for the Visage 7 imaging platform and continued commercialization of Visage RIS.Additionally, the company's performance is expected to be influenced by increased revenue from transaction-based contracts, which are set to commence in fiscal 2025.Earlier, the company reported that its revenue from ordinary activities was AU$161.5 million, up over 29% from AU$124.9 million in the same period last year. The Visible Alpha average estimate was for revenue of AU$160.9 million.The imaging IT provider declared a fully franked final dividend of AU$0.22 per share with a record date of Sept. 5 payable on Sept. 26.Price (AUD): $141.77, Change: $+10.18, Percent Change: +7.74%","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":1,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2459416052"}